KimberlyClark (KMB)
(Delayed Data from NYSE)
$134.61 USD
+0.43 (0.32%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $134.57 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$134.61 USD
+0.43 (0.32%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $134.57 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Zacks News
Top Research Reports for CSX Corporation, Eni & Kimberly-Clark
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including CSX Corporation (CSX), Eni (E) and Kimberly-Clark (KMB).
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
Top Analyst Reports for Merck, Occidental Petroleum & Capital One Financial
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Occidental Petroleum (OXY) and Capital One Financial (COF).
Why Is Kimberly-Clark (KMB) Up 6.3% Since Its Last Earnings Report?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kellogg (K) Discontinues Operations in Crisis-Hit Venezuela
by Zacks Equity Research
Kellogg (K) pulls out of Venezuela citing economic and political disruptions.
Kimberly-Clark Down 9% in 3 Months: Rising Costs the Culprit?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs, lower net selling prices and dismal diaper unit performance.
Zacks Industry Outlook Highlights: Amazon, Sysco, Colgate, Campbell Soup and Kimberly-Clark
by Zacks Equity Research
Zacks Industry Outlook Highlights: Amazon, Sysco, Colgate, Campbell Soup and Kimberly-Clark
Zacks Industry Outlook Highlights: Tyson Foods, Newell Brands, Molson Coors, Sysco and Kimberly Clark
by Zacks Equity Research
Zacks Industry Outlook Highlights: Tyson Foods, Newell Brands, Molson Coors, Sysco and Kimberly Clark
Kimberly-Clark (KMB) Posts In-Line Q1 Earnings, Sales Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2018 results gain from top-line growth across all segments. The company's savings initiative bore positive results.
Kimberly-Clark (KMB) Q1 Earnings & Sales Up Y/Y,Stock Gains
by Zacks Equity Research
Kimberly-Clark (KMB) expects adjusted earnings for 2018 in a range of $6.90-$7.20 per share, reflecting year-over-year growth of 11-16%.
Should Investors Avoid Procter & Gamble (PG) Ahead of Earnings?
by Benjamin Rains
Shares of Procter & Gamble (PG) are down roughly 13% over the last year as the consumer packaged goods giant faces tougher competition from rivals and upstarts. With that said, earnings season could give Procter & Gamble a much needed shot in the arm, if it impresses investors.
Cost-Cutting Plans to Fuel Kimberly-Clark (KMB) Q1 Earnings
by Zacks Equity Research
We remain encouraged about Kimberly-Clark's (KMB) upcoming performance, given its solid FORCE program and recently announced 2018 Global Restructuring plan.
Top Ranked Income Stocks to Buy for April 12nd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 12nd:
These Cosmetic Stocks Scale Fresh Highs: More Room to Run?
by Zacks Equity Research
Constant innovations, product launches and effective initiatives have been favoring Estee Lauder (EL) and Nu Skin. These stocks hit 52-week high yesterday.
Bed Bath & Beyond (BBBY) Q4 Earnings: Is a Beat Likely?
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is on track with its transformation plan, targeting to deliver seamless customer experience. However, soft margin and comps trends remain near-term concerns for the stock.
Can Kimberly-Clark's (KMB) Savings Efforts Uplift the Stock?
by Zacks Equity Research
Kimberly-Clark (KMB) continues to gain from cost-saving efforts and plans to channelize such gains toward investments and restructuring.
Can Buyouts & Cost Savings Aid McCormick's (MKC) Q1 Earnings?
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2018 results to gain from acquisitions as well as productivity enhancing and savings efforts. However, rising input cost is a worry.
Will Newell's (NWL) Transformation Plan Aid a Turnaround?
by Zacks Equity Research
Newell (NWL) is losing luster due to soft core sales, strained margins and adverse pricing. However, its Transformation Plan has the potential to bring it back on growth trajectory.
The Zacks Analyst Blog Highlights: 3M, Walmart, Kimberly-Clark, Automatic Data Processing and T. Rowe Price Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: 3M, Walmart, Kimberly-Clark, Automatic Data Processing and T. Rowe Price Group
5 Top Dividend Aristocrats to Buy in March
by Tirthankar Chakraborty
Investors have been caught off guard following Trump's tariff news and a gradual increase in rates on flared-up cost of living.
Newell (NWL) Beats on Q4 Earnings & Sales, Retains FY18 View
by Zacks Equity Research
Newell's (NWL) results were favorably impacted by ongoing cost savings and related synergies, contributions from acquisitions and lower tax rate.
Clorox to Return More to Shareholders on Tax Reform Benefits
by Zacks Equity Research
Clorox (CLX) accelerated dividend increase announcement in order to reward shareholders with gains from the new tax reform. It raised quarterly dividend by 14% to 96 cents per share.
5 Best Stocks to Buy for a Stock Market Correction
by Tirthankar Chakraborty
The stock market is officially in a 'correction', with both the S&P 500 and the Dow plunging more than 10% from the recent all-time high scaled in January.
The Zacks Analyst Blog Highlights: Brinker International, Kimberly-Clark, Northwest Bancshares, Macy's and Occidental Petroleum
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Brinker International, Kimberly-Clark, Northwest Bancshares, Macy's and Occidental Petroleum
5 Ultra-Safe Stocks to Survive Bloodbath on Wall Street
by Tirthankar Chakraborty
Concerns over inflation and rising interest rates pushed bond yields higher at the expense of stocks.